Literature DB >> 22201301

Superior intellectual ability in schizophrenia: neuropsychological characteristics.

James H MacCabe1, Gildas Brébion, Abraham Reichenberg, Taposhri Ganguly, Peter J McKenna, Robin M Murray, Anthony S David.   

Abstract

OBJECTIVE: It has been suggested that neurocognitive impairment is a core deficit in schizophrenia. However, it appears that some patients with schizophrenia have intelligence quotients (IQs) in the superior range. In this study, we sought out schizophrenia patients with an estimated premorbid Intelligence Quotient (IQ) of at least 115 and studied their neuropsychological profile.
METHOD: Thirty-four patients meeting diagnostic criteria for schizophrenia or schizoaffective disorder, as defined by the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV), with mean estimated premorbid IQ of 120, were recruited and divided into two subgroups, according to whether or not their IQ had declined by at least 10 points from their premorbid estimate. Their performance on an extensive neuropsychological battery was compared with that of 19 IQ-matched healthy controls and a group of 16 "typical" schizophrenia patients with estimated premorbid IQ <110, using one way ANOVAs and profile analysis using MANOVAs.
RESULTS: Schizophrenia patients whose estimated premorbid and current IQ both lay in the superior range were statistically indistinguishable from IQ-matched healthy controls on all neurocognitive tests. However, their profile of relative performance in subtests was similar to that of typical schizophrenia patients. Patients with superior premorbid IQ and evidence of intellectual deterioration had intermediate scores.
CONCLUSIONS: Our results confirm the existence of patients meeting DSM-IV diagnostic criteria for schizophrenia who have markedly superior premorbid intellectual level and appear to be free of gross neuropsychological deficits. We discuss the implications of these findings for the primacy of cognitive deficits in schizophrenia.

Entities:  

Mesh:

Year:  2011        PMID: 22201301     DOI: 10.1037/a0026376

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  10 in total

1.  Impaired musical ability in people with schizophrenia.

Authors:  Sanae Hatada; Ken Sawada; Masanori Akamatsu; Erina Doi; Masayoshi Minese; Motoshi Yamashita; Allen E Thornton; William G Honer; Shimpei Inoue
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

2.  Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.

Authors:  Olav B Smeland; Shahram Bahrami; Oleksandr Frei; Alexey Shadrin; Kevin O'Connell; Jeanne Savage; Kyoko Watanabe; Florian Krull; Francesco Bettella; Nils Eiel Steen; Torill Ueland; Danielle Posthuma; Srdjan Djurovic; Anders M Dale; Ole A Andreassen
Journal:  Mol Psychiatry       Date:  2019-01-04       Impact factor: 15.992

3.  Neurocognitive Decrements are Present in Intellectually Superior Schizophrenia.

Authors:  Anja Vaskinn; Torill Ueland; Ingrid Melle; Ingrid Agartz; Ole A Andreassen; Kjetil Sundet
Journal:  Front Psychiatry       Date:  2014-05-07       Impact factor: 4.157

4.  A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness.

Authors:  Rudolf Uher; Jill Cumby; Lynn E MacKenzie; Jessica Morash-Conway; Jacqueline M Glover; Alice Aylott; Lukas Propper; Sabina Abidi; Alexa Bagnell; Barbara Pavlova; Tomas Hajek; David Lovas; Kathleen Pajer; William Gardner; Adrian Levy; Martin Alda
Journal:  BMC Psychiatry       Date:  2014-12-02       Impact factor: 3.630

5.  Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis.

Authors:  Emily P Hedges; Hannah Dickson; Stefania Tognin; Gemma Modinos; Mathilde Antoniades; Mark van der Gaag; Lieuwe de Haan; Patrick McGorry; Christos Pantelis; Anita Riecher-Rössler; Rodrigo Bressan; Neus Barrantes-Vidal; Marie-Odile Krebs; Merete Nordentoft; Stephan Ruhrmann; Gabriele Sachs; Bart P Rutten; Jim van Os; Lucia R Valmaggia; Philip McGuire; Matthew J Kempton
Journal:  Schizophr Res Cogn       Date:  2021-10-28

6.  Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study.

Authors:  Madeline H Meier; Avshalom Caspi; Abraham Reichenberg; Richard S E Keefe; Helen L Fisher; HonaLee Harrington; Renate Houts; Richie Poulton; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2014-01       Impact factor: 18.112

7.  Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder.

Authors:  H W Moises; D Wollschläger; H Binder
Journal:  Transl Psychiatry       Date:  2015-08-11       Impact factor: 6.222

8.  The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes.

Authors:  Ruth Wells; Vaidy Swaminathan; Suresh Sundram; Danielle Weinberg; Jason Bruggemann; Isabella Jacomb; Vanessa Cropley; Rhoshel Lenroot; Avril M Pereira; Andrew Zalesky; Chad Bousman; Christos Pantelis; Cynthia Shannon Weickert; Thomas W Weickert
Journal:  NPJ Schizophr       Date:  2015-11-04

9.  Neurocognitive normality in schizophrenia revisited.

Authors:  R Walter Heinrichs; Farena Pinnock; Eva Muharib; Leah Hartman; Joel Goldberg; Stephanie McDermid Vaz
Journal:  Schizophr Res Cogn       Date:  2015-11-19

10.  Overdispersed gene expression in schizophrenia.

Authors:  Guangzao Huang; Daniel Osorio; Jinting Guan; Guoli Ji; James J Cai
Journal:  NPJ Schizophr       Date:  2020-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.